-
If you purchased shares of Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
San Diego, Oct. 03, 2011 (Shareholders Foundation) -- The announcement that Pharmaceutical Product Development agreed to be acquired by affiliates of The Carlyle Group and Hellman & Friedman for $33.25 per PPDI share prompted an investigation on behalf of investors of Pharmaceutical Product Development, Inc. (NASDAQ:PPDI)) concerning whether the offer to acquire Pharmaceutical Pro...
You must register (for free) or login to view the entire investigation.
